Quarterly report pursuant to Section 13 or 15(d)

Abeona Therapeutics LLC Acquisition (Tables)

v3.2.0.727
Abeona Therapeutics LLC Acquisition (Tables)
 6 Months Ended
Jun. 30, 2015
Abeona Therapeutics LLC Acquisition [Abstract]  
Schedule of purchase price allocation
Total purchase price
    
Initial consideration
  
$
31,758,000
  
Contingent consideration
    
6,489,000
  
Total purchase price
  
$
38,247,000
  
         
Allocation of the purchase price
        
Cash
  
$
3,697,000
  
Accounts receivable
    
1,000
  
Prepaid expenses
    
28,000
  
Property and equipment
    
51,000
  
Other assets
    
1,000
  
Accounts payable
    
(153,000
)
Total tangible assets
    
3,625,000
  
         
Licensing agreement
    
2,156,000
  
Goodwill
    
38,955,000
  
Contingent consideration liability (6,489,000 )
         
Total net asset value
  
$
38,247,000